MorphoSys AG (XETRA:MOR) - Share price - Overview

Stock Report

MorphoSys AG MOR

Last Price
85.20

Day Change
-0.10|-0.12%

As of 20/04/2018
17:35:06 CEST | EUR
Minimum 15 Minutes Delay.

Last Close85.30
Day Range84.15 - 85.75
Mkt Cap2.48Bil
52-Wk Range51.25 - 88.40
Yield %-
ISINDE0006632003
Volume54,858
P/E-35.35
P/S36.90
P/CF-64.15

Share Price

Financials
201520162017
More ...
Income Statement
Revenue106.2249.7466.79
Operating Income13.11-59.73-67.25
Net Income14.90-60.38-69.83
Basic EPS0.57-2.28-2.41
Avg. Diluted Shares Outstanding262729
Balance Sheet
Current Assets300.12308.06340.68
Non Current Assets99.96155.5474.72
Total Assets400.08463.60415.40
Current Liabilities27.4738.3047.70
Total Liabilities---
Total Equity362.74415.46358.67
Cash Flow
Operating Cash Flow-23.51-46.62-38.45
Capital Expenditure-8.77-2.91-13.15
Free Cash Flow-32.28-49.53-51.59

In millions, except "Basic EPS". Currency is EUR.

Company Profile

MorphoSys AG engages in the development of therapeutic antibodies to cure inflammatory and autoimmune diseases, as well as cancer and infectious diseases. The company operates through two business segments; Partnered Discovery and Proprietary Development.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

326
Key Stats
More ...
Price/Earning TTM-35.39
Price/Book6.92
Price/Sales TTM36.97
Rev Growth (3 year avg)1.44
EPS Growth (3 year avg)-
Operating Margin % TTM-100.69
Net Margin % TTM-104.54
ROE TTM-18.04
Debt/Equity0.00
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.